National Health Investors (NHI) announced that proxy advisory firm Egan-Jones has recommended that stockholders vote on the white proxy card for only NHI’s director nominees – Candice Todd, Robert Chapin, Jr., James Jobe and Robert Adams – in connection with its May 21 annual meeting of stockholders.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- Is NHI a Buy, Before Earnings?
- National Health Investors price target lowered to $83 from $91 at BofA
- Land & Buildings urges National Health stockholders to vote for its nominees
- National Health Investors appoints Robert Chapin Jr. to board of directors
- National Health Investors price target raised to $76 from $70 at Truist